$WW

Oxford Industries, iHeartMedia, AMC Networks, Xponential Fitness, and WeightWatchers shares fell due to a drop in consumer sentiment and higher Treasury yields. The LSEG/Ipsos index fell to 45.2 in October 2026, its lowest since 2011. WeightWatchers, down 58.4% YTD, was notably impacted by GLP-1 drug demand. Higher yields also pressured companies reliant on consumer financing.

H&R Block (HRB) beat earnings estimates and raised guidance, but its stock fell 1.4% to $46.03. Matthews (MATW) reported a 29.6% revenue decline, missing estimates, and its stock dropped 32.5% to $18.68. Service International (SCI) saw a 3.6% revenue increase, beating expectations, but its stock fell 8.5% to $78.37. WeightWatchers (WW) reported a 14.2% revenue decline, beating some estimates but missing others, and its stock dropped 6.5% to $14.41.

Service International (NYSE:SCI) reported Q2 revenue of $1.10B, up 3.6% YoY, beating estimates by 1.8%. Despite a strong quarter, its stock fell 9.7%. H&R Block (NYSE:HRB) also beat estimates, but its stock dropped 8.4%. Matthews (NASDAQ:MATW) missed estimates, with revenue down 29.6% YoY, and its stock fell 29.8%. The consumer discretionary sector saw average revenue growth of 0.3% YoY, with stocks down 13.8% since earnings reports.

WW International (WW) shares rose 8% after Northland initiated coverage with an Outperform rating and $25 target. The firm cited WW's turnaround strategy and partnerships as key to recovery. WW faced challenges from GLP-1 medications and debt, leading to a bankruptcy filing in May 2025. Analysts highlight strategic collaborations with Google, Eli Lilly, and Sam's Club as potential growth drivers.

WeightWatchers (WW) shares fell 10.3% due to declining demand for traditional diet programs amid rising use of GLP-1 weight-loss drugs. The drop follows a previous 6.4% decline, despite a partnership with Google Health Enterprise. WW stock is down 56.1% YTD, trading at $13.80, 60.5% below its 52-week high.

WW International stock rose 10.4% in pre-market trading after announcing a collaboration with Google Health Enterprise, integrating Google's wearable tech with Weight Watchers' wellness programs. The partnership targets the corporate health benefits market and follows a technical breakout above the 200-day moving average. Institutional investors have increased their stakes, with Cygnus Capital Advisors doubling its position and Bank of New York Mellon initiating a new stake.

WeightWatchers (WW) shares fell 14.8% after appointing Stephen Bye as CEO. The company aims for subscription growth and transformation, but investors remain cautious. WW stock is down 51.7% YTD, trading at $15.19, 56.5% below its 52-week high of $34.92.

WW INTERNATIONAL, INC. (WW) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Weight Watchers Appoints Stephen Bye as Chief Executive Officer Seasoned CEO Brings Track Record of Business Transformation, Consumer Subscription Growth and Significant Value Creation NEW YORK, September 9, 2026 — WW International, Inc. (NASDAQ: WW) (“Weight Watcher

H&R Block (HRB) reported Q2 revenue of $1.14B, up 3% YoY, beating estimates by 2.5%. The company raised full-year guidance, and its stock is up 9.2%. Frontdoor (FTDR) also beat expectations, while Matthews (MATW) and Pool (POOL) missed, with stocks down 23.7% and 6%, respectively. WeightWatchers (WW) reported a 14.2% revenue decline but beat EPS estimates, with stock up 15.2%.

Weight Watchers (WW) will participate in the Morgan Stanley Annual Global Healthcare Conference on September 15, 2026, with a live fireside chat at 2:35 p.m. ET. The event will focus on its science-backed weight management approach and healthcare positioning. The live audio webcast and a 90-day replay will be available on the company's investor website. WW's stock gained 3.63% on September 3, 2026, following the announcement.